Scopolamine Transdermal System — FDA Drug Shortage
The FDA lists a drug shortage record for Scopolamine Transdermal System (transdermal system) from Padagis US LLC with status To Be Discontinued. The shortage was first posted on 11/03/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Padagis US LLC
- Package NDC
- 45802-580-46
- Dosage Form
- Transdermal System
- Presentation
- Scopolamine, Transdermal System, 1 mg (NDC 45802-580-46)
- Initial Posting
- 11/03/2025
- Revised Date